Држава: Ирска
Језик: Енглески
Извор: HPRA (Health Products Regulatory Authority)
CALCIUM GLUCONATE, MAGNESIUM HYPOPHOSPHITE, GLUCOSE MONOHYDRATE, BORIC ACID
Norbrook Laboratories Limited
QA12AA20
CALCIUM GLUCONATE, MAGNESIUM HYPOPHOSPHITE, GLUCOSE MONOHYDRATE, BORIC ACID
Unknown
Solution for Injection
LM-Licensed Merchant
Ovine
Calcium (different salts in combination)
Vitamins & Minerals
Authorised
1991-10-01
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Calciject PMD Solution for Injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION For a full list of excipients, see Section 6.1. 3 PHARMACEUTICAL FORM Solution for injection. A clear pale yellow sterile aqueous solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Sheep. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Calciject PMD is indicated in the treatment of hypocalcaemia complicated by a deficiency of magnesium with accompanying hypoglycaemia. 4.3 CONTRAINDICATIONS None. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES No special warnings. Each ml contains: Active Substance Calcium Gluconate 166 mg Boric Acid 34 mg Dextrose Monohydrate 200 mg Magnesium Hypophosphite 50 mg (as hexahydrate) Excipients Chlorocresol (as preservative) 1 mg HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 28/08/2014_ _CRN 7013831_ _page number: 1_ 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS The solution should be warmed to body temperature before administration. Intravenous injections should be given slowly and stopped at the first signs of adverse reaction. Rapid intravenous injection may result in cardiac arrhythmias and, in severely toxaemic animals, collapse and death. As intravenous administration of this product could cause death, this route should only be used by a veterinary surgeon. SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE PRODUCT TO ANIMALS None. 4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS) None known. 4.7 USE DURING PREGNANCY, LACTATION OR LAY Calciject PMD can be safely administered to pregnant and lactating animals. 4.8 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORM Прочитајте комплетан документ